Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
03174 ETF · CSOP Hang Seng Biotech ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -11.37%  | -4.75% | +48.84%  | +8.44% | N/A | -8.11% | -1.65% | -1.65%  | |
| Flows |
Key fund info
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -4.75% | +48.84% | +8.44% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about 03174 ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
03174’s has a Final Sustainability Grade of either B+, B, or B-.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
| AuM | ||
|---|---|---|
03033 | CSOP Hang Seng TECH Index ETF | €9.19B |
07709 | CSOP SK Hynix Daily (2x) Leveraged Product ETF | €2.1B |
03443 | CSOP FTSE Hong Kong Equity ETF | €1.76B |
07226 | CSOP Hang Seng TECH Index Daily (2x) Leveraged Product ETF | €1.51B |
03432 | CSOP MSCI HK China Connect Select ETF | €1.23B |
Established in 2008, CSOP Asset Management Limited holds the distinction of being the inaugural offshore asset manager initiated by a regulated asset management company in China. Principally engaged in investments focused on the Chinese market, CSOP AML is tasked with the management of both public and private funds. Additionally, it offers investment advisory services to Asian and global investors. The scope of CSOP AML's offerings extends to include Exchange Traded Funds (ETFs), among other investment vehicles. As such, it delivers access to broad market exposures as well as a tailored suite of thematic ETFs, designed for investors seeking exposure to distinct themes.
Via Offical websiteFrequently asked questions about 03174
What does CSOP Hang Seng Biotech ETF, 03174, invest in?
03174 is a Passive ETF. This ETF provides exposure to Biotechnology Equities.
Which benchmark or index does 03174 replicate?
03174 tracks the Hang Seng Biotech Index - HKD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of 03174?
03174 carries a total expense ratio (TER) of 1.5%, indicating the annual cost for holding the fund.
When was 03174 launched?
03174 was introduced to the market on July 20, 2021. It trades on Hong Kong
Who is the ETF issuer of 03174?
CSOP Hang Seng Biotech ETF, 03174, is provided by CSOP. Learn more about CSOP here.
What is the current assets under management (AUM) of 03174?
03174 oversees €91M in assets as of March 13, 2026.
How has 03174 performed lately?
Based on data from March 13, 2026, 03174 returned -11.37% over the past month, -4.75% over the last three months and -1.65% year-to-date.
What are the latest inflows or outflows for 03174?
As of March 13, 2026, 03174 recorded net flows of +€1.9M year-to-date.
Does 03174 distribute dividends?
03174 follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of 03174?
As of January 31, 2026, 03174 has significant geographic allocations in Cayman Islands, China and Switzerland.
In which sector or theme does 03174 invest in?
As of January 31, 2026, 03174 focuses largely on Health Care and Consumer Discretionary.
How many securities does 03174 hold and how diversified is it?
As of January 31, 2026, 03174 holds 30 positions in its portfolio, with 82.17% of assets concentrated in its top 15 holdings.
What are the main positions in 03174?
As of January 31, 2026, 03174 top three holdings include WUXI BIOLOGICS (CAYMAN), CH1391448177 and INNOVENT BIOLOGICS INC.
What is the base currency of 03174?
The base currency of 03174 is HKD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
